# Extraction: SOURCE-20251114-1122

**Source**: `SOURCE-20251114-youtube-lecture-a16z-the_brutal_truth_about_biotech_why_2b_per_drug_is_killing_in.md`
**Atoms extracted**: 10
**Categories**: claim, concept, praxis_hook, prediction

---

## Claim (5)

### ATOM-SOURCE-20251114-1122-0002
**Lines**: 15-17
**Context**: consensus / claim
**Tension**: novelty=0.20, consensus_pressure=0.70, contradiction_load=0.10, speculation_risk=0.10, actionability=0.10, epistemic_stability=0.80

> The cost of drug development has exploded to $2.5 billion per approval, driven by "three horsemen" strangling the process.

### ATOM-SOURCE-20251114-1122-0003
**Lines**: 17-20
**Context**: anecdote / evidence
**Tension**: novelty=0.40, consensus_pressure=0.60, contradiction_load=0.20, speculation_risk=0.30, actionability=0.20, epistemic_stability=0.60

> Investigator-initiated trials in Shanghai are rewriting the competitive playbook in biotech faster than American founders can file Investigational New Drug (IND) applications.

### ATOM-SOURCE-20251114-1122-0004
**Lines**: 20-22
**Context**: consensus / claim
**Tension**: novelty=0.30, consensus_pressure=0.60, contradiction_load=0.20, speculation_risk=0.20, actionability=0.10, epistemic_stability=0.70

> The infrastructure that historically built monoclonal antibodies is now a commodity threatening to hollow out the biotech industry.

### ATOM-SOURCE-20251114-1122-0007
**Lines**: 31-32
**Context**: consensus / evidence
**Tension**: novelty=0.40, consensus_pressure=0.60, contradiction_load=0.20, speculation_risk=0.30, actionability=0.20, epistemic_stability=0.70

> China possesses a significant speed and cost advantage in biotech, creating a geographic arbitrage problem for other nations.

### ATOM-SOURCE-20251114-1122-0009
**Lines**: 34-35
**Context**: consensus / evidence
**Tension**: novelty=0.20, consensus_pressure=0.80, contradiction_load=0.10, speculation_risk=0.10, actionability=0.10, epistemic_stability=0.90

> GLP-1s are a drug class that has revitalized the biotech industry.

## Concept (1)

### ATOM-SOURCE-20251114-1122-0006
**Lines**: 29-30
**Context**: consensus / claim
**Tension**: novelty=0.30, consensus_pressure=0.70, contradiction_load=0.10, speculation_risk=0.10, actionability=0.10, epistemic_stability=0.80

> Eroom's Law describes why drug development costs $2 billion and takes longer than ever.

## Praxis Hook (1)

### ATOM-SOURCE-20251114-1122-0005
**Lines**: 22-24
**Context**: method / claim
**Tension**: novelty=0.80, consensus_pressure=0.20, contradiction_load=0.10, speculation_risk=0.70, actionability=0.60, epistemic_stability=0.30

> To compete in biotech, the path forward demands inventing medicines that are literally impossible to make without tools that do not yet exist.

## Prediction (3)

### ATOM-SOURCE-20251114-1122-0001
**Lines**: 14-15
**Context**: speculation / claim
**Tension**: novelty=0.70, consensus_pressure=0.30, contradiction_load=0.10, speculation_risk=0.80, actionability=0.10, epistemic_stability=0.40

> The next Genentech will not resemble the previous one.

### ATOM-SOURCE-20251114-1122-0008
**Lines**: 33-34
**Context**: speculation / claim
**Tension**: novelty=0.70, consensus_pressure=0.30, contradiction_load=0.10, speculation_risk=0.90, actionability=0.40, epistemic_stability=0.30

> AI in drug development has the potential to reduce the cost of a $2.5 billion drug to $500 million.

### ATOM-SOURCE-20251114-1122-0010
**Lines**: 35-36
**Context**: speculation / claim
**Tension**: novelty=0.60, consensus_pressure=0.30, contradiction_load=0.10, speculation_risk=0.80, actionability=0.30, epistemic_stability=0.40

> Aging will be treated before its underlying mechanisms are fully understood.
